The Evolution of AIFA Registries to Support Managed Entry Agreements for Orphan Medicinal Products in Italy

por Xoxi, Entela, Facey, Karen M, Cicchetti, Americo
Publicado 2021

Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and Tisagenlecleucel

por Facey, Karen M., Espin, Jaime, Kent, Emma, Link, Angèl, Nicod, Elena, O’Leary, Aisling, Xoxi, Entela, van de Vijver, Inneke, Zaremba, Anna, Benisheva, Tatyana, Vagoras, Andrius, Upadhyaya, Sheela
Publicado 2021